The pharmaceutical industry is dedicated to the discovery, development and constant improvement of medicines. This process of continuous innovation includes manufacturing under conditions that ensure their safety, quality and distribution, as well as post-marketing surveillance (pharmacovigilance).
Pharmaceutical development is generally a long and complex process, involving a variety of collaborations.
Our expertise in funding for the pharmaceutical industry
We provide support in funding all of your pharmaceutical development projects through these four areas of expertise.
Innovation funding in the pharmaceutical industry
Tax aspects of research and innovation for pharma and CROs
Funding of pharmaceutical industry stakeholders
The pharmaceutical industry in France
The pharmaceutical industry in France can be described as a major sector of activity, bringing together over 300 companies. It is an essential player in public health, supporting the public authorities, particularly in controlling healthcare costs.
Pharmaceutical companies allocate a considerable budget to Research and Development (R&D), which represents more than 10% of their turnover. This research effort is vital for human health and quality of life.
The particularity of drug companies is the very strict regulatory framework set by the Public Health Code. A drug can only be marketed if it has been approved by the French National Agency for the Safety of Medicines “ANSM” or the European Medicines Agency (EMA). Therefore, the drug receives a Marketing Authorization (MA) which guarantees its quality, safety and efficiency.
Our clients share their experiences...
The EVOLY Consulting consultants have been able to understand our R&D activities. Their collaborative work methodology proved to be very efficient and much less time-consuming than what I initially thought.